Gabapentin

Product NDC: 68788-7049
11-digit product format: 687887049
Labeler code: 68788
Product ID: 68788-7049_39a762a0-d0af-4c4d-8260-9c67c2c7741d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Gabapentin
Dosage form: TABLET
Route: ORAL
Labeler: Preferred Pharmaceuticals Inc.
Application: ANDA202764
Marketing category: ANDA
Marketing start: 2017-10-31
Marketing end: 0000-00-00
Substance: GABAPENTIN
Active strength: 600 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	68788-7049		I	Inactivated by FDA	2026-08-11
excluded package	package	68788-7049	68788-7049-1	I	Inactivated by FDA	2026-08-11
excluded package	package	68788-7049	68788-7049-3	I	Inactivated by FDA	2026-08-11
excluded package	package	68788-7049	68788-7049-6	I	Inactivated by FDA	2026-08-11
excluded package	package	68788-7049	68788-7049-8	I	Inactivated by FDA	2026-08-11
excluded package	package	68788-7049	68788-7049-9	I	Inactivated by FDA	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 114 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68788-7049-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68788-7049-8	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68788-7049-9	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68788-7049-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68788-7049-6	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68788-7049-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68788-7049-8	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68788-7049-9	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68788-7049-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68788-7049-6	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68788-7049-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68788-7049-8	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68788-7049-9	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68788-7049-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68788-7049-6	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68788-7049-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68788-7049-8	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68788-7049-9	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68788-7049-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68788-7049-6	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68788-7049-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68788-7049-8	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68788-7049-9	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68788-7049-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68788-7049-6	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68788-7049-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68788-7049-8	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68788-7049-9	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68788-7049-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68788-7049-6	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68788-7049-3	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68788-7049-8	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68788-7049-9	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68788-7049-1	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68788-7049-6	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68788-7049-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68788-7049-8	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68788-7049-9	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68788-7049-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68788-7049-6	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68788-7049-3	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68788-7049-8	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68788-7049-9	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68788-7049-1	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68788-7049-6	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68788-7049-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68788-7049-8	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68788-7049-9	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68788-7049-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68788-7049-6	`ad56d346431e…`	`cc804d4bbf1e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202764-001	GABAPENTIN	GABAPENTIN	600MG	TABLET / ORAL			2012-10-16
A202764-002	GABAPENTIN	GABAPENTIN	800MG	TABLET / ORAL			2012-10-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202764-001	GABAPENTIN	600MG	TABLET / ORAL		2012-10-16	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A202764-002	GABAPENTIN	800MG	TABLET / ORAL		2012-10-16	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202764-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2012-10-16	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A202764-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2012-10-16	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 52 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202764-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202764-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A202764-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202764-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A202764-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202764-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A202764-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202764-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A202764-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202764-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A202764-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202764-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202764-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202764-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A202764-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202764-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A202764-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202764-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A202764-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202764-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A202764-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202764-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A202764-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202764-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A202764-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202764-001	AB1	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202764-002	AB1	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202764-001	AB1	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A202764-002	AB1	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202764-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A202764-002	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202764-001	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202764-002	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202764-001	AB	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202764-002	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202764-001	AB	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202764-002	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202764-001	AB	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202764-002	AB	1	`3f0d92c62455…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
68788-7049-1	These highlights do not include all the information needed to use gabapentin tablets, USP safely and effectively. See full prescribing information for gabapentin tablets, USP GABAPENTIN Tablets, USP for Oral Use Initial U.S. Approval:1993
68788-7049-3	These highlights do not include all the information needed to use gabapentin tablets, USP safely and effectively. See full prescribing information for gabapentin tablets, USP GABAPENTIN Tablets, USP for Oral Use Initial U.S. Approval:1993
68788-7049-6	These highlights do not include all the information needed to use gabapentin tablets, USP safely and effectively. See full prescribing information for gabapentin tablets, USP GABAPENTIN Tablets, USP for Oral Use Initial U.S. Approval:1993
68788-7049-8	These highlights do not include all the information needed to use gabapentin tablets, USP safely and effectively. See full prescribing information for gabapentin tablets, USP GABAPENTIN Tablets, USP for Oral Use Initial U.S. Approval:1993
68788-7049-9	These highlights do not include all the information needed to use gabapentin tablets, USP safely and effectively. See full prescribing information for gabapentin tablets, USP GABAPENTIN Tablets, USP for Oral Use Initial U.S. Approval:1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68788-7049-1	Gabapentin	100 in 1 BOTTLE	TABLET	100	2
68788-7049-3	Gabapentin	30 in 1 BOTTLE	TABLET	30	2
68788-7049-6	Gabapentin	60 in 1 BOTTLE	TABLET	60	2
68788-7049-8	Gabapentin	120 in 1 BOTTLE	TABLET	120	2
68788-7049-9	Gabapentin	90 in 1 BOTTLE	TABLET	90	2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68788-7049-8	EA - Each	68788-7049	74f4d1c7-f01d-4c03-9664-a071888a1961	1	2024-04-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68788-7049	GABAPENTIN TABLET [PREFERRED PHARMACEUTICALS INC.]	2	Legacy NDC, 5 package rows	20191001_d9f836d6-4442-4d31-a47a-14a744574c8c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GABAPENTIN	GABAPENTIN	Exelan Pharmaceuticals Inc.	323dad14-ded9-4432-a265-c957e46cc6db	2023-03-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202764 application number: ANDA202764
Gabapentin	GABAPENTIN	Cipla USA Inc.	7c3ac86f-b8f7-42bf-942a-db854d946e54	2023-01-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202764 application number: ANDA202764
Gabapentin	GABAPENTIN	Proficient Rx LP	f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3a	2021-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202764 application number: ANDA202764

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310433	gabapentin 600 MG Oral Tablet	PSN	d9f836d6-4442-4d31-a47a-14a744574c8c	2
310433	gabapentin 600 MG Oral Tablet	SCD	d9f836d6-4442-4d31-a47a-14a744574c8c	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68788-7049-1	68788704901	100 in 1 BOTTLE	Historical
68788-7049-3	68788704903	30 in 1 BOTTLE	Historical
68788-7049-6	68788704906	60 in 1 BOTTLE	Historical
68788-7049-8	68788704908	120 in 1 BOTTLE	Historical
68788-7049-9	68788704909	90 in 1 BOTTLE	Historical